查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1751007

2025年尿液检查全球市场报告

Genomic Urine Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年基因组尿液检查市场规模将快速成长。到 2029 年，该市场规模将成长到 16.2 亿美元，年复合成长率（CAGR）为 12.5%。预测期内的预期增长可归因于液态切片方法的采用率不断提高、对个性化医疗的日益重视、慢性肾臟病率的不断上升、对家庭诊断检测解决方案的日益关注以及多体学方法在尿液检测中的应用不断扩大。预测期内预计的主要趋势包括非侵入性诊断方法的开发、高灵敏度测试面板的进步、机器学习技术的整合、尿液外泌体分离的创新以及单细胞尿液测序的进展。

慢性肾臟病负担的持续加重预计将在未来几年推动基因组尿液检查市场的扩张。慢性肾臟病是指肾臟受损，无法再有效过滤血液，导致废物和体液在体内积聚的一种疾病。这是因为高血糖会损害肾臟血管，降低过滤能力。基因组尿液检查能够早期发现基因标记，从而支持慢性肾臟病的管理，以便及时干预和製定个人化治疗方案。这种方法透过促进更准确的监测和减缓疾病进展来改善患者的预后。例如，2024年6月，澳洲政府机构澳洲健康与福利研究所报告称，慢性肾臟病的死亡率从2021年的4.2%上升到2022年的6.2%。因此，慢性肾臟病负担的不断加重正在促进基因组尿液检查市场的成长。

尿液检查产业的主要企业正专注于次世代定序等创新进展，以提高各种疾病非侵入性诊断测试的准确性、灵敏度和早期发现的可能性。次世代定序是一种复杂的 DNA 定序方法，透过同时对数百万个 DNA 片段进行定序，可以快速、准确、大规模地分析遗传物质。例如，2023 年 5 月，美国生物技术公司 Convergent Genomics Inc. 宣布推出其尿液检查UroAmp。此检测利用新一代 DNA定序检测与膀胱癌相关的 60 个基因突变，可在症状出现前 12 年实现早期检测。它提供全面的基因数据以支持诊断、治疗计划和復发监测，比细胞学和膀胱镜检查等传统技术更准确。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球基因组尿液检查PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球尿液检查市场：成长率分析
  • 全球尿液检查市场表现：规模与成长，2019-2024
  • 全球尿液检查市场预测：规模与成长，2024-2029 年，2034 年
  • 全球尿液检查总目标市场（TAM）

第六章市场区隔

  • 全球尿液检查市场（依检测类型、表现及预测），2019-2024 年、2024-2029 年、2034 年
  • 去氧核糖核酸（DNA）检测
  • 核糖核酸（RNA）检测
  • 微生物学
  • 表观遗传检测
  • 全球尿液检查市场：依通路、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院药房
  • 通讯药房
  • 专业药房
  • 全球尿液检查市场：应用、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 癌症诊断
  • 感染疾病
  • 遗传疾病筛检
  • 健康监测
  • 全球尿液检查市场：依最终用户、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 诊断实验室
  • 研究和学术机构
  • 其他最终用户
  • 全球尿液检查市场细分（依去氧核糖核酸检测类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 种系突变分析
  • 体细胞突变检测
  • 拷贝数变异（CNV）检测
  • 单核苷酸多态性分析
  • 全球尿液检查市场细分（按 RNA 检测类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 基因表现
  • 信使RNA分析
  • 非编码RNA检测
  • 融合转录本的检测
  • 全球尿液检查市场细分（依微生物检测类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 尿液微生物组分析
  • 病原体鑑定
  • 抗生素抗药性基因检测
  • 定量微生物负荷分析
  • 全球尿液检查市场细分（按表观遗传检测类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 去氧核糖核酸甲基化分析
  • 组蛋白修饰分析
  • 染色质可及性测试

第七章 区域和国家分析

  • 全球尿液检查市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球尿液检查市场：依国家/地区、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 基因组尿液检查市场：竞争格局
  • 基因组尿液检查市场：公司简介
    • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Illumina Inc.
  • Myriad Genetics Inc.
  • ARUP Laboratories
  • MedGenome Labs Ltd
  • GENETWORx LLC
  • MDxHealth SA
  • Nucleix Ltd.
  • Pacific Edge Ltd
  • Convergent Genomics Inc.
  • LynxDx Inc.
  • miR Scientific
  • RYND Biotech
  • UGenDx Ltd
  • Guardant Health
  • Exact Sciences

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年尿液检查市场：提供新机会的国家
  • 2029年尿液检查市场：细分领域带来新机会
  • 2029年尿液检查市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r34860

Genomic urine testing is a non-invasive diagnostic approach that examines genetic material found in urine to identify specific biomarkers associated with various diseases, including cancer, infections, and genetic disorders. This method integrates genomics with advanced molecular techniques to detect mutations, gene expression profiles, or microbial DNA (deoxyribonucleic acid). Its main goal is early disease detection, ongoing monitoring, and the development of personalized treatment strategies for different health conditions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types of genomic urine testing include DNA testing, RNA testing, microbial testing, and epigenetic testing. DNA (deoxyribonucleic acid) testing is a scientific technique used to study an individual's genetic makeup to determine biological relationships, verify identity, or uncover inherited health conditions. These tests are distributed through several channels, such as hospital pharmacies, mail-order pharmacies, and specialty pharmacies. Genomic urine tests are applied in areas such as cancer detection, infectious disease diagnosis, genetic disorder screening, and general health assessment. They cater to a broad spectrum of end users, including hospitals and clinics, diagnostic labs, research and academic institutions, and other healthcare providers.

The genomic urine testing market research report is one of a series of new reports from The Business Research Company that provides genomic urine testing market statistics, including the edge artificial intelligence integrated circuits industry global market size, regional shares, competitors with the genomic urine testing market share, detailed genomic urine testing market segments, market trends, and opportunities, and any further data you may need to thrive in the genomic urine testing industry. This genomic urine testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The genomic urine testing market size has grown rapidly in recent years. It will grow from$0.90 billion in 2024 to $1.01 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth during the historical period can be credited to the rising occurrence of urologic cancers, heightened demand for early cancer diagnosis, increased awareness of precision medicine, a growing number of genetic disorder cases, and expanding investments in biomarker research.

The genomic urine testing market size is expected to see rapid growth in the next few years. It will grow to$1.62 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The anticipated growth in the forecast period can be attributed to the rising adoption of liquid biopsy methods, an increasing emphasis on personalized medicine, a growing prevalence of chronic kidney diseases, heightened focus on at-home diagnostic testing solutions, and the expanding application of multi-omics approaches in urine-based testing. Key trends expected during the forecast period include the development of non-invasive diagnostic methods, advancement of high-sensitivity testing panels, integration of machine learning technologies, innovations in urine exosome isolation, and progress in single-cell urine sequencing.

The growing burden of chronic kidney disease is anticipated to drive the expansion of the genomic urine testing market in the coming years. Chronic kidney disease is a condition where the kidneys are damaged and unable to effectively filter blood, leading to an accumulation of waste and fluids in the body. This burden is increasing largely due to the rising prevalence of diabetes, as high blood sugar levels can damage kidney blood vessels, reducing their filtering capability. Genomic urine testing supports the management of chronic kidney disease by enabling early detection of genetic markers, which allows for timely intervention and personalized treatment plans. This approach improves patient outcomes by facilitating more accurate monitoring and slowing disease progression. For example, in June 2024, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that mortality rates due to chronic kidney disease increased from 4.2% in 2021 to 6.2% in 2022. As a result, the escalating burden of chronic kidney disease is contributing to the growth of the genomic urine testing market.

Leading companies in the genomic urine testing industry are concentrating on innovative advancements, such as next-generation sequencing, to improve the precision, sensitivity, and early detection potential of non-invasive diagnostic tests for various illnesses. Next-generation sequencing is a sophisticated DNA sequencing method that facilitates fast, accurate, and large-scale analysis of genetic material by sequencing millions of DNA fragments simultaneously. For instance, in May 2023, Convergent Genomics Inc., a biotechnology company based in the United States, introduced the genomic urine test UroAmp. This test utilizes next-generation DNA sequencing to detect mutations in 60 genes linked to bladder cancer, allowing for early detection up to 12 years before symptoms appear. It offers comprehensive genetic data to support diagnosis, treatment planning, and recurrence monitoring, delivering greater accuracy than conventional techniques such as cytology and cystoscopy.

In September 2024, A. Menarini Diagnostics, an in-vitro diagnostics company headquartered in Italy, formed a partnership with Nucleix Ltd. The collaboration is focused on the commercialization and distribution of Bladder EpiCheck, a non-invasive genomic urine test designed for the early detection and monitoring of bladder and upper tract urothelial cancers throughout Europe. This initiative enhances the availability of advanced cancer diagnostic tools and aligns with clinical guidelines in Europe. Nucleix Ltd. is an Israel-based molecular diagnostics firm that specializes in epigenetic and genomic testing technologies.

Major players in the genomic urine testing market are Eurofins Scientific SE, Thermo Fisher Scientific, Abbott Laboratories, Laboratory Corporation of America Holdings, Hologic Inc., Illumina Inc., Myriad Genetics Inc., ARUP Laboratories, MedGenome Labs Ltd, GENETWORx LLC, MDxHealth SA, Nucleix Ltd., Pacific Edge Ltd, Convergent Genomics Inc., LynxDx Inc., miR Scientific, RYND Biotech, UGenDx Ltd.

North America was the largest region in the genomic urine testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in genomic urine testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the genomic urine testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genomic urine testing market includes of revenues earned by entities by providing services such as early disease detection, genetic mutation analysis, cancer screening, infection diagnostics, personalized treatment planning, and monitoring of disease progression through non-invasive urine-based genomic profiling. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genomic Urine Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genomic urine testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genomic urine testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genomic urine testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Testing Type: Deoxyribonucleic Acid (DNA) Testing; Ribonucleic Acid (RNA) Testing; Microbial Testing; Epigenetic Testing
  • 2) By Distribution Channel: Hospital Pharmacies; Mail Order Pharmacies; Speciality Pharmacies
  • 3) By Application: Cancer Diagnosis; Infectious Diseases; Genetic Disorder Screening; Health Monitoring
  • 4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Research And Academic Institutions; Other End Users
  • Subsegments:
  • 1) By Deoxyribonucleic Acid Testing: Germline Mutation Analysis; Somatic Mutation Detection; Copy Number Variation (CNV) Testing; Single Nucleotide Polymorphism Analysis
  • 2) By Ribonucleic Acid Testing: Gene Expression Profiling; Messenger Ribonucleic Acid Analysis; Non-coding Ribonucleic Acid Detection; Fusion Transcript Detection
  • 3) By Microbial Testing: Urinary Microbiome Profiling; Pathogen Identification; Antimicrobial Resistance Gene Detection; Quantitative Microbial Load Analysis
  • 4) By Epigenetic Testing: Deoxyribonucleic Acid Methylation Analysis; Histone Modification Profiling; Chromatin Accessibility Testing
  • Companies Mentioned: Eurofins Scientific SE; Thermo Fisher Scientific; Abbott Laboratories; Laboratory Corporation of America Holdings; Hologic Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genomic Urine Testing Market Characteristics

3. Genomic Urine Testing Market Trends And Strategies

4. Genomic Urine Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Genomic Urine Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Genomic Urine Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Genomic Urine Testing Market Growth Rate Analysis
  • 5.4. Global Genomic Urine Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Genomic Urine Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Genomic Urine Testing Total Addressable Market (TAM)

6. Genomic Urine Testing Market Segmentation

  • 6.1. Global Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deoxyribonucleic Acid (DNA) Testing
  • Ribonucleic Acid (RNA) Testing
  • Microbial Testing
  • Epigenetic Testing
  • 6.2. Global Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Mail Order Pharmacies
  • Speciality Pharmacies
  • 6.3. Global Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Diagnosis
  • Infectious Diseases
  • Genetic Disorder Screening
  • Health Monitoring
  • 6.4. Global Genomic Urine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Research And Academic Institutions
  • Other End Users
  • 6.5. Global Genomic Urine Testing Market, Sub-Segmentation Of Deoxyribonucleic Acid Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Germline Mutation Analysis
  • Somatic Mutation Detection
  • Copy Number Variation (CNV) Testing
  • Single Nucleotide Polymorphism Analysis
  • 6.6. Global Genomic Urine Testing Market, Sub-Segmentation Of Ribonucleic Acid Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gene Expression Profiling
  • Messenger Ribonucleic Acid Analysis
  • Non-coding Ribonucleic Acid Detection
  • Fusion Transcript Detection
  • 6.7. Global Genomic Urine Testing Market, Sub-Segmentation Of Microbial Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urinary Microbiome Profiling
  • Pathogen Identification
  • Antimicrobial Resistance Gene Detection
  • Quantitative Microbial Load Analysis
  • 6.8. Global Genomic Urine Testing Market, Sub-Segmentation Of Epigenetic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deoxyribonucleic Acid Methylation Analysis
  • Histone Modification Profiling
  • Chromatin Accessibility Testing

7. Genomic Urine Testing Market Regional And Country Analysis

  • 7.1. Global Genomic Urine Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Genomic Urine Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genomic Urine Testing Market

  • 8.1. Asia-Pacific Genomic Urine Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genomic Urine Testing Market

  • 9.1. China Genomic Urine Testing Market Overview
  • 9.2. China Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genomic Urine Testing Market

  • 10.1. India Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genomic Urine Testing Market

  • 11.1. Japan Genomic Urine Testing Market Overview
  • 11.2. Japan Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genomic Urine Testing Market

  • 12.1. Australia Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genomic Urine Testing Market

  • 13.1. Indonesia Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genomic Urine Testing Market

  • 14.1. South Korea Genomic Urine Testing Market Overview
  • 14.2. South Korea Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genomic Urine Testing Market

  • 15.1. Western Europe Genomic Urine Testing Market Overview
  • 15.2. Western Europe Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genomic Urine Testing Market

  • 16.1. UK Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genomic Urine Testing Market

  • 17.1. Germany Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genomic Urine Testing Market

  • 18.1. France Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genomic Urine Testing Market

  • 19.1. Italy Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genomic Urine Testing Market

  • 20.1. Spain Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genomic Urine Testing Market

  • 21.1. Eastern Europe Genomic Urine Testing Market Overview
  • 21.2. Eastern Europe Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genomic Urine Testing Market

  • 22.1. Russia Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genomic Urine Testing Market

  • 23.1. North America Genomic Urine Testing Market Overview
  • 23.2. North America Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genomic Urine Testing Market

  • 24.1. USA Genomic Urine Testing Market Overview
  • 24.2. USA Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genomic Urine Testing Market

  • 25.1. Canada Genomic Urine Testing Market Overview
  • 25.2. Canada Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genomic Urine Testing Market

  • 26.1. South America Genomic Urine Testing Market Overview
  • 26.2. South America Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genomic Urine Testing Market

  • 27.1. Brazil Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genomic Urine Testing Market

  • 28.1. Middle East Genomic Urine Testing Market Overview
  • 28.2. Middle East Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genomic Urine Testing Market

  • 29.1. Africa Genomic Urine Testing Market Overview
  • 29.2. Africa Genomic Urine Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Genomic Urine Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Genomic Urine Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genomic Urine Testing Market Competitive Landscape And Company Profiles

  • 30.1. Genomic Urine Testing Market Competitive Landscape
  • 30.2. Genomic Urine Testing Market Company Profiles
    • 30.2.1. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Genomic Urine Testing Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Myriad Genetics Inc.
  • 31.3. ARUP Laboratories
  • 31.4. MedGenome Labs Ltd
  • 31.5. GENETWORx LLC
  • 31.6. MDxHealth SA
  • 31.7. Nucleix Ltd.
  • 31.8. Pacific Edge Ltd
  • 31.9. Convergent Genomics Inc.
  • 31.10. LynxDx Inc.
  • 31.11. miR Scientific
  • 31.12. RYND Biotech
  • 31.13. UGenDx Ltd
  • 31.14. Guardant Health
  • 31.15. Exact Sciences

32. Global Genomic Urine Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genomic Urine Testing Market

34. Recent Developments In The Genomic Urine Testing Market

35. Genomic Urine Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Genomic Urine Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Genomic Urine Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Genomic Urine Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250617_r34860_Genomic_Urine_Testing_GMR_2025